Collection and Distribution of Biospecimens for Novel Research Uses
NCT03848962 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2022-11-09
Summary
iSpecimen aims to create a clinical partner network of hospitals, laboratories, academic institutions, and other healthcare organizations ("institutions") capable of providing researchers and educators ("researchers") with annotated biospecimens for use in biomarker discovery and validation; diagnostic test and instrumentation development and validation; therapeutics development; other medical research including the impact that various specimen collection and handling methods and conditions have on research results; and in education such as researcher or physician training (collectively "research").
Conditions
- Cancer
- Healthy
- Gastrointestinal Complication
- Autoimmune Diseases
- Infectious Disease
- Women's Health: High-Risk Pregnancy
- Dermatologic Disease
- Blood Disease
Sponsors & Collaborators
-
iSpecimen Inc
lead INDUSTRY
Eligibility
- Min Age
- 1 Month
- Max Age
- 89 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-06-30
- Primary Completion
- 2025-12-31
- Completion
- 2026-12-31
Countries
- United States
Study Locations
More Related Trials
-
COVID-19 Immunity Assessment
NCT05080231 ·Status: COMPLETED
-
A Normal Donor Sample Collection Study in Healthy Adults
NCT01318863 ·Status: COMPLETED
-
Collection and Distribution of Samples From Healthy Donors for In Vitro Research at the NCI-Frederick
NCT00339911 ·Status: ENROLLING_BY_INVITATION
-
Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 Infection
NCT05669261 ·Status: UNKNOWN ·Phase: PHASE1
-
Collection of Human Biological Samples for the Development and Validation of New Methods of Diagnosis and for the Realization of Expertises Diagnostics in the Field of Infectious Diseases and Tropical
NCT03912246 ·Status: COMPLETED ·Phase: NA
-
Controls and Healthy Vasculature Initiative
NCT05403151 ·Status: RECRUITING
-
Blood Collection for Use in Serological Assay Development From Healthy Adult Volunteers
NCT00500032 ·Status: COMPLETED ·Phase: NA
-
COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability
NCT05584189 ·Status: COMPLETED ·Phase: NA
-
Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19
NCT06311435 ·Status: RECRUITING ·Phase: NA
-
Evaluation of MiSeq for Microbial Identification in Specimens
NCT02578875 ·Status: COMPLETED
-
ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings
NCT04352764 ·Status: UNKNOWN
-
Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use
NCT00001846 ·Status: RECRUITING
-
Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19
NCT04403035 ·Status: WITHDRAWN
-
Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development
NCT00401232 ·Status: COMPLETED ·Phase: NA
-
Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies
NCT00067054 ·Status: RECRUITING
-
COVID Card Pilot Study to Detect Antibodies to SARS-CoV-2
NCT05196932 ·Status: COMPLETED
-
Blood and Urine Sample Collection From Healthy Volunteers
NCT05154409 ·Status: COMPLETED
-
Evaluation of Blood Gas Syringes
NCT01935284 ·Status: COMPLETED
-
Detection of Covid-19 in Tissue Samples of Orthopedic Origin
NCT04916561 ·Status: COMPLETED
-
Assessment of Stability of Mail-in Capillary Hemoglobin A1c Test Kit
NCT00511030 ·Status: COMPLETED
-
Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test
NCT04597047 ·Status: UNKNOWN ·Phase: NA
-
Phase I/II Safety, Dose Finding & Antiviral Activity of RD-X19 in Mild/Moderate Outpatient COVID-19
NCT04662671 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 (COVID-19) IgG Antibody Test in Fingerstick Whole Blood
NCT04699903 ·Status: COMPLETED
-
Cellular-Mediated Immunity in COVID-19
NCT04746521 ·Status: UNKNOWN
-
Evaluation of a Device That Separates Blood Cells From Serum/Plasma
NCT02853448 ·Status: COMPLETED ·Phase: NA